Difference between revisions of "Ghuwalewala S, et al. Stem Cell Res. (2016) cited as Ref 755 in DOI: 10.1038/s41392-020-0110-5 (Q10018)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2016, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 405-417, #quickstatements; #temporary_batch_1590074839150) |
||
(3 intermediate revisions by the same user not shown) | |||
Property / Published In Name String | |||
+ | Stem Cell Res. | ||
Property / Published In Name String: Stem Cell Res. / rank | |||
+ | Normal rank | ||
Property / Volume | |||
+ | 16 | ||
Property / Volume: 16 / rank | |||
+ | Normal rank | ||
Property / title | |||
+ | CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma (English) | ||
Property / title: CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma (English) / rank | |||
+ | Normal rank | ||
Property / Page(s) | |||
+ | 405-417 | ||
Property / Page(s): 405-417 / rank | |||
+ | Normal rank |
Latest revision as of 15:51, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Ghuwalewala S, et al. Stem Cell Res. (2016) cited as Ref 755 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Ghuwalewala S
0 references
2016
0 references
Stem Cell Res.
0 references
16
0 references
CD44(high)CD24(low) molecular signature determines the cancer stem cell and EMT phenotype in oral squamous cell carcinoma (English)
0 references
405-417
0 references